All Stories

  1. Mechanisms and Pathophysiology of Obesity: Upgrading a Complex Scenario

    Article • Current Medicinal Chemistry, February 2020, Bentham Science Publishers

    Tommaso Angelone

  2. Physiological levels of chromogranin A prevent doxorubicin-induced cardiotoxicity without impairing its anticancer activity

    Article • The FASEB Journal, April 2019, Federation of American Societies For Experimental Biology (FASEB)

    Tommaso Angelone, CARMINE ROCCA, Angelo Corti

  3. The Gn RH analogues affect novel neuropeptide SMIM 20/phoenixin and GPR 173 receptor expressions in the female rat hypothalamic–pituitary–gonadal ( HPG ) axis

    Article • Clinical and Experimental Pharmacology and Physiology, February 2019, Wiley

    Tommaso Angelone

  4. Role of NLRP-3 Inflammasome in Hypertension: A Potential Therapeutic Target

    Article • Current Pharmaceutical Biotechnology, November 2018, Bentham Science Publishers

    Professor Pasquale Pagliaro, Tommaso Angelone, CARMINE ROCCA

  5. Biological Roles of the Eclectic Chromogranin-A-derived Peptide Catestatin

    Article • Current Medicinal Chemistry, October 2017, Bentham Science Publishers

    Tommaso Angelone

  6. pGlu-serpinin protects the normotensive and hypertensive heart from ischemic injury

    Article • September 2015, Bioscientifica

    Y. Peng Loh, Tommaso Angelone

  7. Nesfatin-1 and the Cardiovascular System: Central and Pheripheral Actions and Cardioprotection

    Article • Current Drug Targets, August 2015, Bentham Science Publishers

    Tommaso Angelone